Research graph
References from Cost-Effectiveness Analysis for Cardiovascular Magnetic Resonance Imaging. Local targets link to admitted publications; unresolved targets remain external evidence.
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
10.1161/cir.0000000000001123 · 2023 · External reference
Medicare services provided by cardiologists in the United States: 1999-2008
10.1161/circoutcomes.111.961813 · 2012 · External reference
Recent Trends and Potential Drivers of Non-invasive Cardiovascular Imaging Use in the United States of America and England
2020 · External reference
Cardiovascular imaging payment and reimbursement systems: understanding the past and present in order to guide the future
10.1016/j.jcmg.2014.01.008 · 2014 · External reference
Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance
10.1186/1532-429x-15-52 · 2013 · External reference
Foundations of cost-effectiveness analysis for health and medical practices
10.1056/nejm197703312961304 · 1977 · External reference
Measurement of health state utilities for economic appraisal
10.1016/0167-6296(86)90020-2 · 1986 · External reference
Cost, effectiveness, and cost-effectiveness
10.1161/circoutcomes.108.793406 · 2009 · External reference
Recommendations of the Panel on Cost-effectiveness in Health and Medicine
10.1001/jama.1996.03540150055031 · 1996 · External reference
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine
10.1001/jama.1996.03540160061034 · 1996 · External reference
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine
10.1001/jama.1996.03540140060028 · 1996 · External reference
The influence of time horizon on results of cost-effectiveness analyses
10.1080/14737167.2017.1331432 · 2017 · External reference
Cost-effectiveness Thresholds Used by Study Authors, 1990-2021
10.1001/jama.2023.1792 · 2023 · External reference
Economic foundations of cost-effectiveness analysis
10.1016/s0167-6296(96)00506-1 · 1997 · External reference
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
10.1016/j.jacc.2014.03.016 · 2014 · External reference
Cost-effectiveness analysis in the assessment of diagnostic imaging technologies
10.1148/radiol.2352040330 · 2005 · External reference
The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis
10.7326/m14-0027 · 2015 · External reference
Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes
10.1016/j.jcmg.2020.02.029 · 2020 · External reference
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
10.1056/nejmoa0807611 · 2009 · External reference
Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany
10.1186/1532-429x-15-30 · 2013 · External reference
10.1186/1532-429x-14-35
10.1186/1532-429x-14-35 · 2012 · External reference
Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease
10.1186/1532-429x-16-13 · 2014 · External reference
Performance figures of invasive cardiology in Germany 2006 and 2007 focussing on coronary artery disease
10.1007/s00392-010-0244-5 · 2011 · External reference
Low diagnostic yield of elective coronary angiography
10.1056/nejmoa0907272 · 2010 · External reference
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario
10.1001/jama.2013.7834 · 2013 · External reference
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry
10.1186/s12968-015-0222-1 · 2016 · External reference
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
10.1016/j.jcmg.2021.11.008 · 2022 · External reference
Magnetic resonance perfusion or fractional flow reserve in coronary disease
10.1056/nejmoa1716734 · 2019 · External reference
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study
10.1136/heartjnl-2013-303624 · 2013 · External reference
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
10.1016/s0140-6736(11)61335-4 · 2012 · External reference
Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease
10.1093/ehjqcco/qcw008 · 2016 · External reference
Cost-effectiveness of cardiovascular imaging for stable coronary heart disease
10.1136/heartjnl-2020-316990 · 2021 · External reference
Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach
10.1136/openhrt-2021-001700 · 2022 · External reference
10.1136/bmjopen-2013-003419
10.1136/bmjopen-2013-003419 · 2014 · External reference
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy
10.3310/hta18590 · 2014 · External reference
Economy – Cost effectiveness
2020 · External reference
Modeling the cost and health impacts of diagnostic strategies in patients with suspected transthyretin cardiac amyloidosis
10.1161/jaha.122.026308 · 2022 · External reference
Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease
10.1186/s12968-021-00833-1 · 2022 · External reference
The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): Resources and Outcomes Impact
10.1161/circimaging.116.005171 · 2016 · External reference
Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care
10.1016/j.jcmg.2011.04.016 · 2011 · External reference
Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S
10.1080/13696998.2019.1580713 · 2019 · External reference
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine
10.1001/jama.1996.03540140060028 · ExternalCitation · doi-reference
Recommendations of the Panel on Cost-effectiveness in Health and Medicine
10.1001/jama.1996.03540150055031 · ExternalCitation · doi-reference
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine
10.1001/jama.1996.03540160061034 · ExternalCitation · doi-reference
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario
10.1001/jama.2013.7834 · ExternalCitation · doi-reference
Cost-effectiveness Thresholds Used by Study Authors, 1990-2021
10.1001/jama.2023.1792 · ExternalCitation · doi-reference
Performance figures of invasive cardiology in Germany 2006 and 2007 focussing on coronary artery disease
10.1007/s00392-010-0244-5 · ExternalCitation · doi-reference
Measurement of health state utilities for economic appraisal
10.1016/0167-6296(86)90020-2 · ExternalCitation · doi-reference
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
10.1016/j.jacc.2014.03.016 · ExternalCitation · doi-reference
Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care
10.1016/j.jcmg.2011.04.016 · ExternalCitation · doi-reference
Cardiovascular imaging payment and reimbursement systems: understanding the past and present in order to guide the future
10.1016/j.jcmg.2014.01.008 · ExternalCitation · doi-reference
Cost-effectiveness analysis of stress cardiovascular magnetic resonance imaging for stable chest pain syndromes
10.1016/j.jcmg.2020.02.029 · ExternalCitation · doi-reference
Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
10.1016/j.jcmg.2021.11.008 · ExternalCitation · doi-reference
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
10.1016/s0140-6736(11)61335-4 · ExternalCitation · doi-reference
Economic foundations of cost-effectiveness analysis
10.1016/s0167-6296(96)00506-1 · ExternalCitation · doi-reference
Foundations of cost-effectiveness analysis for health and medical practices
10.1056/nejm197703312961304 · ExternalCitation · doi-reference
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention
10.1056/nejmoa0807611 · ExternalCitation · doi-reference
Low diagnostic yield of elective coronary angiography
10.1056/nejmoa0907272 · ExternalCitation · doi-reference
Magnetic resonance perfusion or fractional flow reserve in coronary disease
10.1056/nejmoa1716734 · ExternalCitation · doi-reference
Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S
10.1080/13696998.2019.1580713 · ExternalCitation · doi-reference
The influence of time horizon on results of cost-effectiveness analyses
10.1080/14737167.2017.1331432 · ExternalCitation · doi-reference
Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease
10.1093/ehjqcco/qcw008 · ExternalCitation · doi-reference
10.1136/bmjopen-2013-003419
10.1136/bmjopen-2013-003419 · ExternalCitation · doi-reference
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study
10.1136/heartjnl-2013-303624 · ExternalCitation · doi-reference
Cost-effectiveness of cardiovascular imaging for stable coronary heart disease
10.1136/heartjnl-2020-316990 · ExternalCitation · doi-reference
Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach
10.1136/openhrt-2021-001700 · ExternalCitation · doi-reference
Cost-effectiveness analysis in the assessment of diagnostic imaging technologies
10.1148/radiol.2352040330 · ExternalCitation · doi-reference
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
10.1161/cir.0000000000001123 · ExternalCitation · doi-reference
The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): Resources and Outcomes Impact
10.1161/circimaging.116.005171 · ExternalCitation · doi-reference
Cost, effectiveness, and cost-effectiveness
10.1161/circoutcomes.108.793406 · ExternalCitation · doi-reference
Medicare services provided by cardiologists in the United States: 1999-2008
10.1161/circoutcomes.111.961813 · ExternalCitation · doi-reference
Modeling the cost and health impacts of diagnostic strategies in patients with suspected transthyretin cardiac amyloidosis
10.1161/jaha.122.026308 · ExternalCitation · doi-reference
10.1186/1532-429x-14-35
10.1186/1532-429x-14-35 · ExternalCitation · doi-reference
Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany
10.1186/1532-429x-15-30 · ExternalCitation · doi-reference
Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance
10.1186/1532-429x-15-52 · ExternalCitation · doi-reference
Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease
10.1186/1532-429x-16-13 · ExternalCitation · doi-reference
Cost-minimization analysis of three decision strategies for cardiac revascularization: results of the “suspected CAD” cohort of the european cardiovascular magnetic resonance registry
10.1186/s12968-015-0222-1 · ExternalCitation · doi-reference
Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease
10.1186/s12968-021-00833-1 · ExternalCitation · doi-reference
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy
10.3310/hta18590 · ExternalCitation · doi-reference
The optimal imaging strategy for patients with stable chest pain: a cost-effectiveness analysis
10.7326/m14-0027 · ExternalCitation · doi-reference
